Dr. Moris J. Danon is a nationally and internationally known neuromuscular disease specialist and nerve and muscle pathologist. In 1981 he described a novel muscle disease that was consequently named after him (Danon disease).
Chief of Neurology, Hospital for Special Surgery
Professor of Clinical Neurology, Weill Cornell Medical College
Study in phase contrast microscopy
Electron microscopy of nerve and muscle
NIH Contract Grant, 2002
Awaraded NIH grant: Co-investigator with Dr. Arthur Weinstein, 1994
Awarded MDA grant: Co-investigator with Dr. Joseph Etlinger, 1996
Awarded NIH grant: Co-investigator with Dr. A. Omachi, 1978
Awarded PHS-GRSG Grant, 1976
American Academy of Neurology, Fellow
New York Academy of Sciences
Industry Relationships |
One of the goals of Hospital for Special Surgery (HSS) is to advance the science of orthopedic surgery, rheumatology, and related disciplines for the benefit of patients. Physicians at HSS may collaborate with outside companies for education, research and medical advances. HSS supports this collaboration in order to foster medical breakthroughs; however HSS also believes that these collaborations must be disclosed.
As part of the disclosure process, this website lists physician collaborations with outside companies if payments were received during the prior year, or if the HSS physician currently receives payment. The disclosures are provided by information provided by the physician and other sources and are updated regularly. Further information may be available on individual company websites.
As of May 13, 2009, Dr. Danon reported no financial interest relationships with healthcare industry.
By disclosing the collaborations of HSS physicians with industry on this website, HSS and its physicians make this information available to their patients and the public, thus creating a transparent environment for those who are interested in this information. Further, HSS’ Conflicts of Interest Policy does not permit physicians to collect royalties on products developed by him/her that are used on patients at HSS.
MD, Graduate University of Istanbul, Turkey
Northwestern University, Neurology, Chicago, Illinois, 1971
St. Vincent's Hospital and Medical Center, Neurology, New York, 1973
Montreal Neurological Institute McGill University, Clinical and Research Fellow in Electromyography, Montreal, Canada, 1974
Montreal Neurological Institute McGill University, Research Fellow in Nerve/Muscle Histopathology and Histochemistry, Montreal, Canada, 1975
American Board of Psychiatry and Neurology
New York State Department of Health Certificate: Laboratory Director for Neuromuscular Pathology
Lamperti C, Danon MJ, Schotland DL, Musumeci O, Slonim A, Krishna S, DiMauro S. Progressive Plyglucosan Deposition in Phophofructokinase Deficient Human Muscle. Muscle and Nerve.
Latov et all (Danon MJ). The Neuropahty Association Medical Advisory Committee. Special Article: Guidelines for the diagnosis of chronic inflammatory demyelination neuropathy. J or periph nerv syst 2003. 8: 282-284.
Raben N, Danon MJ, Gilbert AL, Dwivedi S, Collins B, Thurberg BL, Mattacuabi RJ, Nagarju K, Plotz PH. Enzyme Replacement Therapy in Mouse Model of Pompe Disease. Molecualr Genetics and Metabolism. 2003; 80:159-169.
Sander HW, Golden M, Danon MJ. Quadriplegic areflexic ICU illness: Selective thick filament loss and normal nerve histology. Muscle and Nerve, 2002; 26:499-505.
Shiselfeld LH, Danon MJ. Relationship of skeletal muscle glycogen from wild type and genetically modified mice to their phosphorylase activity. BBRC 2002; 290:874-877.
For more publications, please see the PubMed listing.
©2009 Hospital for Special Surgery. 535 East 70th Street, New York, NY 10021